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Abstract
Background: D-serine is an important coagonist at the NR1 subunit of the NMDA receptor class of glutamate
receptors. It is chiefly synthesized in the CNS by serine racemase (SR). Regulation of SR activity is still poorly
understood. As step toward developing reagents and methods for investigating SR in vitro, we analyzed structure-
function relationships of a recombinant enzyme of human sequence.
Results: Michaelis-Menten kinetic analysis indicated a KM value of 14 mM and Vmax value of 3.66 μmol·mg
-1·hr
-1
when L-serine was used as a substrate for purified SR. Gel-filtration chromatography and protein cross-linking
experiments revealed that dimer is the major oligomeric form of recombinant SR in aqueous solution, though the
proportions of monomer, tetramer, and larger aggregates differed somewhat with the specific buffer used. These
buffers also altered activity in a manner correlating with the relative abundance of dimer. Activity assays showed
that the dimeric gel-filtration fraction held the highest activity. Chemical reduction with DTT increased the activity
of SR by elevating Vmax; cystamine, a reagent that blocks sulfhydryl groups, abolished SR activity. Gel-filtration
chromatography and western blot analysis indicated that DTT enhanced the recovery of noncovalent SR dimer.
Conclusions: These data suggest that SR is most active as a noncovalent dimer containing one or more free
sulfhydryls in the enzyme’s active center or a modulatory site. Buffer composition and reduction/oxidation status
during preparation can dramatically impact interpretations of SR activity. These findings also highlight the
possibility that SR is sensitive to oxidative stress in vivo.
Background
When substantial levels of endogenous D-serine in the
mammalian brain were discovered by Hashimoto et al.
[1], the source of this unusual amino acid became a cri-
tical question. This intrigue was settled when Wolosker
et al. [2] cloned the full-length mouse serine racemase
(SR) gene and purified the enzyme from rat brain.
These discoveries helped to legitimize D-serine as an
endogenous signaling molecule. Colocalization of D-ser-
ine with NMDA receptor (NMDAR) expression in most
parts of the brain [3,4], together with the fact that
degradation of D-serine abolishes NMDAR neurotrans-
m i s s i o ni nd i f f e r e n tb r a i nr e g i o n s[ 5 , 6 ] ,s u p p o r t e dt h e
notion that D-serine is an important endogenous ligand
for the NMDAR, participating broadly in synaptic events
associated with development, plasticity, learning,
memory and excitotoxicity. Mice bearing a loss-of-func-
tion mutation in SR or targeted deletion of the gene
show an 80-90% decrease in brain D-serine levels [7,8].
They also display behavioral phenotypes relevant to
schizophrenia, including deficits in spatial object discri-
mination and long-term memory. These findings are
consistent with compelling evidence that NMDAR hypo-
function contributes to schizophrenia [9], as well as less
complete data implicating D-serine deficiencies in this
important human disorder [10]. In addition, evidence
indicates that SR is directly involved in age-related defi-
cits in hippocampal cognitive function [11] and the
pathogenesis of amyotrophic lateral sclerosis [12].
Highly conserved in mammalian species, SR is a pyri-
doxal-5’-phosphate (PLP)-dependent enzyme which
directly converts L-serine to D-serine. Enzymology stu-
dies of SR reveal that SR activity is modulated in many
ways by various factors. SR activity is elevated by PLP
[2], magnesium, ATP [13,14], calcium [15], and D-serine
[16,17]; inhibition of SR activity has been reported for
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P I P 2[ 2 1 ] .F u r t h e r m o r e ,S R activity is augmented by
physical interactions with other proteins, such as gluta-
mate-receptor-interacting protein (GRIP) [22,23] and
protein interacting with C kinase (PICK1) [24,25].
We previously found that proinflammatory conditions
in microglia elevated the steady-state levels of an SR
dimer that was apparent even in reducing, denaturing
gel electrophoresis [26,27]. This phenomenon was
accompanied by elevated production of D-serine, sug-
gesting that this stable dimer was responsible for high
specific activity. The native structure of recombinant
mouse SR was determined by gel-filtration chromatogra-
phy to exist in a dimer-tetramer equilibrium in solutions
[15]. Native SR purified from mouse brain has a relative
mobility consistent with a mass of 55 kDa, which is
assumed to be a dimer [13]. Recently, the crystal struc-
tures of human and rat SR preparations with two muta-
tions (C2D, C6D) also indicated a dimeric structure for
this enzyme [28]. It has been reported that oxidation of
sulfhydryl groups inhibits SR activity [2,15], but how the
redox state of sulfydryl groups affects SR structure is
unknown. In this study, the relationship between the
structure and activity of SR by reducing and oxidizing
sulfydryl group was investigated.
Results
Purification and enzymatic characterization of
recombinant human SR
For these studies, SR cDNA was amplified by RT-PCR
from human RNA and cloned into pTrcHisB, a prokar-
yotic expression vector that encodes an in-frame
polyhistidine domain at the protein’sN - t e r m i n u s .
Expressed protein was purified on a nickel-charged affi-
nity resin. Expression of the protein yielded about 4 mg
of purified protein from 1 L of bacteria culture. The
protein in each fraction collected from affinity columns
was detected by SDS-PAGE, which showed a very dense
band of SR at 40 kDa (the approximate molecular
weight of human SR monomer with the polyhistidine
f u s i o n )a n di n d i c a t e dt h a tt h i ss t r a t e g yo fa f f i n i t yc h r o -
matography provided protein that was ~90% pure.
The activity of purified SR was assessed for Michaelis-
Menten kinetics (Figure 1), which indicated a KM value
of 14 mM when L-serine was used as a substrate. The
Vmax of SR was 3.66 μmol·mg
-1·hr
-1 at 37°C. These
results are similar to data reported previously for recom-
binant mouse SR protein and purified SR from mouse
brain [2,15].
Oligomeric structure of SR
To study the oligomeric structure of SR under native
conditions, recombinant SR eluted from affinity column
was loaded on a gel-filtration column (Superdex HR200)
which resolves proteins in approximately the 10- to 600-
kDa molecular-mass range. The elution profile of SR is
depicted in Figure 2. Calibration of the column using
protein standards and interpolation of the elution
volume of SR gave theoretical molecular masses for SR
peaks. The first peak eluted at 8.05 min, which fell into
the void volume of the column determined by blue dex-
tran, representing a large protein aggregate. The second
peak at 11.55 min with theoretical molecular mass 189
kDa probably indicates a tetramer. The third peak at
Figure 1 Kinetic characterization of recombinant human SR. A. Michaelis-Menten plot of the activity of recombinant SR versus increasing
concentrations of L-Ser; B. Double-reciprocal plot (Lineweaver-Burk) of the data with the axes 1/V versus 1/[L-Ser]. SR activity assay was
performed as described under “Methods”.
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likely represents a dimer. The forth peak appears as a
shoulder on the third peak at 14.85 min; its theoretical
molecular mass of 45.35 kDa suggests the monomer.
The results from gel filtration revealed that dimer is the
major oligomeric structure of recombinant SR. There
are, however, small amounts of tetrameric and mono-
meric SR in solution.
To confirm the dimeric structure of SR, we fixed pro-
tein quaternary structure by using protein cross-linker
bis(sulfosuccinimidyl)suberate (BS
3). BS
3 contains an
amine-reactive N-hydroxysulfosuccinimide (NHS) ester
at each end of an 8-carbon spacer arm, which reacts
with protein primary amines at pH 7-9 to form amide
bonds resistant to SDS and reducing reagents. First, BS
3
was applied to cross-link recombinant SR. The SDS-
PAGE (Figure 3A) after the cross-linking reaction
showed that with increasing concentrations of BS
3,S R
monomer decreased while dimeric band became denser,
indicating that dimer is present in recombinant SR pre-
p a r a t i o n s .T h e r ew a saf a i n tb a n dj u s ta b o v e1 7 0k D a
when SR was treated with 10, 30 or 100 μMB S
3, which
may be cross-linked SR tetramer. In addition, one cross-
linked band was observed between 100 kDa and 130
kDa; this may be formed by dimeric SR and a small
contaminating bacteria protein, based on preliminary
sequencing data (unpublished results). In addition to
these bands, there were a few high molecular-weight
aggregates formed during the cross-linking reaction
which were trapped in sample loading wells. To study
the quaternary structure of SR in cellular cytosol, BS
3
was applied to cytosol extracted from mouse primary
astrocytes. After cross-linking reactions, western blot
analysis with anti-SR antibody showed that BS
3 treat-
ment decreased SR monomer while increasing its
dimeric form (Figure 3B), suggesting that SR dimer is
also a product of its normal cellular environment.
Dimer is more active than monomer
Several different buffers have been used to purify
recombinant SR in previously published studies. The
effects of Tris-based and phosphate-based buffers on SR
activity and structure were tested here. First, SR was
purified with affinity chromatography and dialyzed
against a phosphate buffer (50 mM sodium phosphate,
pH 8.0, 52 mM NaCl) or a Tris buffer (50 mM Tris-
HCl, pH 8.0, 150 mM NaCl). SR in each buffer was
Figure 2 Gel-filtration chromatography of recombinant SR.
Purified recombinant SR with affinity column was extensively
dialyzed against 50 mM phosphate buffer, pH 8.0, 52 mM NaCl.
After concentration with Centricon filters, aliquots of 50 μlo f~ 3
mg/ml of recombinant SR were loaded onto a Superdex HR200 gel-
filtration column. Separation was performed at 25°C with flow rate
at 0.5 ml/min. The elution buffer was the same as dialysis buffer.
Protein detection was performed at 280 nm.
Figure 3 Stabilization of in vitro-a n din vivo-formed multimers by chemical cross-linker. A. Increasing concentrations of BS
3 were
incubated with 12.5 μM recombinant SR on ice for 2 h, then the reactions were quenched by addition of Tris-HCl. Reaction samples were
analyzed on 10% SDS-PAGE with 2.5% b-mercaptoethanol in the sample buffer. B. Increasing concentrations of protein cross-linker BS
3 were
incubated with lysates from mouse primary astrocytes (0.5 μg protein/μl) on ice for 2 h, and the reactions were quenched by the addition of
Tris-HCl. The formation of cross-linked SR protein was analyzed by western blot with an anti-SR antibody.
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sis revealed a KM of 14 mM in phosphate buffer and 24
mM in Tris buffer; the Vmax of the enzyme was 3.66
μmol.mg
-1.hr
-1 in phosphate buffer and 2.06 μmol.mg
-1.
hr
-1 in Tris buffer (Table 1). These results indicated that
in phosphate buffer SR has higher affinity to L-serine
and greater velocity of racemization reaction than in
Tris buffer.
To determine what structural change(s) resulted in
such a difference in kinetic character of SR in these two
buffers, the oligomeric structure of SR was analyzed
with gel-filtration chromatography (Figure 5). Interest-
ingly, the elution profiles showed that in phosphate buf-
fer the major conformation of SR was dimer along with
a small amount of tetramer, while in Tris buffer the
major species was monomer with a small dimer peak.
Also, the percentage of large protein aggregates was
greater in Tris buffer than in phosphate buffer. To con-
firm that this difference was not caused by the chroma-
tography itself or other experimental manipulations, 3-
(N-morpholino)propanesulfonic acid (MOPS) was used
as the buffer in a gel-filtration separation. The results in
MOPS buffer were similar to those in phosphate buffer:
a large dimer peak and a small tetramer peak (data not
shown).
Because the SR monomer peak in phosphate buffer
and SR dimer peak in Tris buffer were small, it was
impossible to compare dimer and monomer activity in
either single buffer. Moreover, isolated monomer or
dimer might be expected to re-equilibrate to a propor-
tional mixture of the two after fractionation. But the
differing effects of Tris and phosphate buffers on SR
quaternary structure provides an opportunity to examine
mixtures in which the proportion of dimer differs stably.
Gel-filtration fractions of the dimer eluted with phos-
phate buffer and monomer eluted with Tris buffer were
collected and compared in an enzyme activity assay with
10 mM L-Ser. The dimeric preparation produced D-Ser
at a rate of 0.253 ± 0.047 μmol.mg
-1 .hr
-1,w h e r e a st h e
value for the monomeric preparation was 0.108 ± 0.010
μmol.mg
-1.hr
-1 (p ≤ 0.01).
Cysteine residues are critical to activity and structure of
SR
Protein resolving as dimeric in gel-filtration chromato-
graphy could potentially include covalent and/or nonco-
valent dimers. Human SR has eight cysteine residues,
creating ample opportunity for a variety of redox-based
modifications including disulfide bonds. Such disulfides
could act as a bridge to create covalent dimers of SR
when occurring intermolecularly, but even intramolecu-
lar disulfides could place conformational restraints on
the protein’s structure. In addition, the free thiol group
of a cysteine residue is important for the enzymatic
mechanism of many enzymes. We tested the roles of
Figure 4 Influence of buffer components on SR activity.
Recombinant SR purified by affinity chromatography was dialyzed
against a phosphate-buffered (solid line) or Tris-buffered solution
(dashed line). Then, SR activity of each enzyme preparation was
monitored as described under “Methods” except for the reaction
buffers, which corresponded to each respective dialysis buffer.
Table 1 Effect of buffer components on SR activity.
Phosphate Tris
KM (mM) 14 ± 1.5 24 ± 4.0
Vmax (μmol mg-1 hr-1) 3.664 ± 0.166 2.056 ± 0.180
Figure 5 Influence of buffer components on quaternary
structure of recombinant SR. Recombinant SR purified by affinity
chromatography was dialyzed against a phosphate-buffered (solid
line) or Tris-buffered solution (dashed line). After concentration with
Centricon filters, 50-μl aliquots of ~3 mg/ml of each recombinant SR
were loaded onto a Superdex HR200 gel-filtration column and
eluted with same buffer as the corresponding dialysis buffer.
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tion of redox status and utilization of sizing
chromatography.
In preparations of recombinant SR purified only
through the initial step of nickel affinity chromatogra-
phy, reactions containing the thiol-reducing reagent
DTT showed higher enzymatic activity; this effect was
manifested as a dramatic increase in Vmax (Figure 6).
The effect of DTT on SR quaternary structure was
assessed with gel-filtration chromatography. The elution
profile revealed that DTT decreased the amounts of
both the large aggregate and the tetramer while increas-
ing the amount of dimer; monomer amounts were vir-
tually unchanged (Figure 7).
These results suggest that some of the SR in aggregate
and tetramer pools was multimerized by covalent disul-
fide bonds. This conclusion was supported by western
blot analysis of SR eluted directly from the nickel affinity
column (Figure 8A) or of dimeric fractions eluted from
the gel-filtration column (Figure 8B). For the initial SR
preparation obtained from the nickel affinity column,
dialysis in the presence of DTT produced protein that
entirely denatured to monomer in the presence of SDS.
Dialysis in the absence of DTT produced protein that
was resolved by non-reducing SDS-PAGE into large
aggregates, tetramer, and dimer. These multimers were
partially reduced to monomer when DTT was included
in the SDS-PAGE sample buffer. Similar results were
seen with dimeric SR obtained from the gel-filtration col-
umn with or without DTT in the chromatography buffer.
To assess the role of covalent bonds in activity, we
compared the activities of SR dimeric fractions eluted
from the gel-filtration column with or without DTT
added to the chromatography buffer (Figure 9). The
activity of SR dimer in the presence of DTT was signifi-
cantly greater than that of dimer lacking DTT. Addition
of DTT into the reaction buffer enhanced the activity of
dimer purified without DTT, but this step still produced
lower activity than dimer purified in the presence of
DTT; this relative ranking generally reflected the level of
SR isolated as dimer under native conditions but
appearing as monomer in SDS-PAGE (Figure 8B), i.e.,
non-covalent dimer.
To investigate the relevance of disulfide bonds for SR
in a cellular context, lysates of mouse primary astrocytes
were resolved under non-reducing (Figure 10A) and
reducing (Figure 10B) SDS-PAGE. SR protein was
detected by western blot analysis. SR monomer was
detected only under reducing conditions. Combined
with the results of cross-linking experiments (Figure
3B), these data indicate that intermolecular disulfide
bonds could be formed in native SR dimers, at least
when intracellular redox status is altered, e.g., after
depletion of glutathione or aberrant production of reac-
tive oxygen species.
The conformational consequences of disulfides are
apparent from the above data, but other types of
Figure 6 Chemical reduction elevates SR activity by increasing
its Vmax. SR activity assay was performed in the phosphate buffer
with 2.5 μg recombinant enzyme and the indicated concentrations
of L-serine; DTT was alternatively excluded (solid line) or included
(dashed line) at 0.2 mM. After incubation at 37°C for 30 min, the
reaction was terminated by boiling for 5 min. D-ser formation was
monitored by a chemiluminescence assay. The data are
representative of three different protein preparations.
Figure 7 Effect of chemical reduction on quaternary structure
of recombinant SR: native conditions. Recombinant SR purified
by affinity chromatography was dialyzed against the phosphate
buffer with (dashed line) or without (solid line) 0.2 mM DTT. After
concentration with Centricon filters, 50-μl aliquots of ~10 mg/ml of
each recombinant SR were injected onto a Superdex 200 column
and eluted with the same buffer as the dialysis buffer.
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cipation in the catalytic mechanism of an enzyme. To
further address the role of free sulfhydryl groups in
catalysis, we tested the effect of cystamine, a reagent
capable of blocking free thiol groups. Cystamine dra-
matically inhibited the activity of SR dimers (Figure 9).
Discussion
Physiological activation of the NMDARs requires liga-
tion of both the glutamate binding site (on NR2 subu-
nits) and what has been termed the “glycineB“ site (on
NR1 subunits). There is considerable evidence that the
dominant agonist for the NR1 site in most parts of
brain is not glycine but D-serine [3,4]. As the only
known enzyme to synthesize this novel neurotransmitter
in vivo, SR has drawn increasing attention for its role
Figure 8 Effect of chemical reduction on quaternary structure of recombinant SR: denaturing conditions. A. Recombinant SR was
dialyzed against phosphate buffers with or without 0.2 mM DTT after elution from the nickel affinity column. B. SR preparations in panel A were
injected onto a Superdex HR200 column and eluted with same buffer as the corresponding dialysis buffer. Recombinant SR oligomeric species
of both protein preparations in A and B were subjected to SDS-PAGE in presence or absence of 0.2 mM DTT in the sample loading buffer. The
gels were then immunoblotted with anti-SR antibody.
Figure 9 T h er o l eo ff r e es u l f h y d r y l si na c t i v i t yo fS Rd i m e r s .
Dimeric fractions of recombinant SR were eluted from a Superdex
200 column with or without DTT (0.2 mM) in the mobile phase. SR
activity was then assayed. The -DTT fraction was assayed with or
without DTT (0.2 mM) or cystamine (1 mM) in the reaction buffer.
(**p < 0.0001).
Figure 10 SR protein from a cellular source oxidizes to dimers
and other multimers. Total cellular protein was prepared from
three cultures of mouse primary astrocytes and resolved by 10%
SDS-PAGE in the absence (A) or presence (B) of 2.5% b-
mercaptoethanol in the sample buffer. SR protein (arrow) was
detected by western blot with anti-SR antibody. Lane 1 contained
molecular weight standards (kDa).
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tion of glutamatergic synapse activity. In this study we
describe the relationship between structural and func-
tional characterization of SR.
Gel-filtration chromatography and cross-linking
experiments demonstrated that the major oligomeric
structure of recombinant human SR is a dimer. Cross-
linking experiments in cell culture also suggested that
SR dimer is present in intact cells. One surprising dis-
covery is that recombinant SR had different oligomeric
compositions in Tris- and phosphate-based buffers. In
phosphate buffer SR is predominantly dimer with a
small amount of tetramer, whereas in Tris buffer the
major species is monomer with a small dimer peak. By
contrast, Smith et al. [28] reported that recombinant SR
based on the human and rat sequences were dimeric
during gel-filtration chromatography with a Tris-based
buffer. This distinction may involve differences in the
SR primary sequence. Smith et al. introduced missense
mutations (Cys2® Arg and Cys8® Arg) in order to
improve solubility because their production yield was
low. Because cysteine residues are so important for SR
activity and structure-particularly quaternary structure-
those mutants are not comparable to the wild-type
sequence we used. In another case, SR was extracted
and sequentially purified from mouse brain with an
anion-exchange column in Tris-HCl buffer, a Q-sephar-
ose column in Tris-HCl buffer, and hydroxylapatite col-
umn in phosphate buffer [13]. The enzyme was then
resolved with a gel-filtration column in Tris-HCl buffer,
which indicated a species with an apparent size of 55
kDa. Because 55 kDa is between the sizes expected for
monomer (37 kDa) and dimer (74 kDa), this finding is
difficult to interpret. Though the reason for the buffer’s
effect is still unknown, this phenomenon permitted a
comparison of activity across conditions that favor
monomer versus dimer formation. The results support
the conclusion that dimer has higher activity as phos-
phate buffer resulted in both more dimer and more
activity. In addition, phosphate buffer is probably closer
to physiological conditions than is Tris. Thus, phosphate
buffers would seem more appropriate than Tris buffers
for biochemical analysis of SR.
The effects of DTT on SR’s activity are prominent.
The influence of DTT on enzyme’s structure includes
two possibilities: First, DTT may keep the thiol group
of critical cysteine residue(s) in a reduced state. The
critical residue(s) may reside in the active site of the
enzyme and be important in catalysis of enzyme reac-
tions or reside outside the active site and be critical in
modulating the enzyme reactions allosterically. Second,
DTT may prevent or break randomly formed disulfide
bonds between cysteine residues outside of the active
center, thereby helping the protein to fold correctly
during synthesis/purification in this recombinant
system.
Blocking of free sulfhydryl groups by cystamine dra-
matically decreased SR activity, which indicates a key
role for a cysteine residue(s) in the active site and/or a
modulatory site. One previous study [18] mentioned
that murine SR protein with Cys217® Ser mutation is
basally inactive, which may indicate that Cys217 is
located in the SR active site and involved in catalysis.
Also, Cys113 in mouse SR was reported to be S-nitrosy-
lated by NO to form S-nitrosothiol (SNO), leading to a
dramatic inhibition of enzyme activity [18]. Structural
analysis reveals that the ATP-binding site is in close
proximity to Cys113, and nitrosylation of Cys113 inter-
feres with ATP binding to SR [18]. If the structure of
the free thiol group of Cys113 is critical for ATP binding
to SR, other types of covalent modification of Cys113
including a disulfide bond between Cys113 and any other
cysteine residue is very likely to have the same effect on
ATP binding as nitrosylation of Cys113.C y s 217 and
Cys113 are both conserved evolutionarily, suggesting that
disulfide bonds between these residues, either intra- or
intermolecularly, accounts for the cross-species similari-
ties documented by Mustafa et al. vis-à-vis our results.
In addition to S-nitrosylation, cysteine residue can
undergo a broad range of post-translational redox modi-
fications by diverse reactive oxygen species (ROS) and
reactive nitrogen species (RNS). The ability to cycle
between different redox states and the specificity toward
oxidative reactions endow the cysteine residue with
properties consistent with it being a participant in
redox-based physiological signal transduction or modu-
lation [29]. Hydrogen peroxide can oxidize the cysteine
residue in the catalytic center of protein tyrosine phos-
phatases (PTPs) to sulphenic acid (S-OH), abolishing
the catalytic activity of the cysteine residue as a phos-
phate acceptor [30]. RNS such as NO and peroxynitrite
are reportedly able to produce sulphenic acid in the oxi-
dation of thiol compounds [31]. In many cases, sulphe-
nic acid reacts rapidly with other cysteine thiols to form
disulfide bonds (S-S). These disulfide bonds can be
formed either intramolecularly or intermolecularly, the
latter connecting two subunits in one complex or two
different quaternary complexes.
As the major covalent connection between peptides,
the disulfide bond plays a very important role in protein
folding, polymerization, and activity regulation [32],
which was also tested in SR here. Under some circum-
stances, a mixed disulfideb o n di sf o r m e db e t w e e n
cysteine residues in proteins and the small molecule glu-
tathione, an event known as S-glutathionylation (pro-
tein-SSG). Accumulating evidence implicates S-
glutathionylation in many pathological conditions such
as neurodegenerative diseases, cancer, lung diseases,
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tions of a robust oxidative burst, sulphenic moieties of
cysteine residues can be progressively oxidized to sulphi-
nic acid (R-SO2H) and sulphonic acid (R-SO3H). While
S-nitrosothiol (SNO), sulphenic acid (S-OH), disulfide
bonds (S-S), and S-glutathionylation (protein-SSG) can
be reduced by glutathione and/or thioredoxin in biologi-
cal system, formation of sulphinic acid (R-SO2H) and
sulphonic acid (R-SO3H) is believed to be irreversible.
Hence, these two hyperoxidized thiol moieties are not
considered to be involved in reversible redox signaling
[34].
This study also supports the second potential effect of
DTT on the enzyme’s structure: creating conditions per-
missive for optimal flexibility of the structure. DTT
facilitated release of non-covalent dimer from large
aggregates and tetramers, suggesting that during sub-
strate binding and/or catalysis, SR enzyme may need to
change its conformation to make the active center more
suitable for substrate and the positions of critical amino
acids more accurate for catalysis. This is confirmed by
recent findings from a SR crystallization study [28],
which demonstrated that the tertiary structure of SR has
large and small domains connected by a loop region.
During the racemization reaction, the small domain
appears capable of a large degree of flexibility to cor-
rectly orientate the substrate L-serine close to active site
for catalysis. Compared to non-covalent dimer, disul-
fide-linked dimer is less likely to change conformation
freely, which may explain its lower catalytic ability.
Thus, the flexibility of the enzyme protein appears to be
important for its function.
We previously found that inflammatory activation of
microglia elevated the levels of a stable SR dimer and
D-serine production [26,27,35]. This finding suggested
that an apparent covalent dimer was responsible for
enzymatic activity. Activation of microglia typically
involves a programmatic superoxide production from
NADPH oxidase, and this dramatically enhances the
oxidation conditions in the cells. It is possible that
these conditions result in oxidative crosslinking of the
SR subunits. This may involve disulfide bonds, but the
species induced by microglial activation was stable to
DTT and b-mercaptoethanol. Moreover, the data
reported here indicate that disulfide-linked dimers are
actually less active than noncovalent dimers, arguing
against any connection between formation of the
stable dimer and elevated D-serine production in acti-
vated microglia. It seems more likely, therefore, that
the stable dimer observed in activated microglia
results from some chemical conjugation of amino
acids other than cystine disulfides. For example,
superoxide dismutase has been found to aggregate
through several forms of covalent bonds arising from
a tryptophanyl radical [36]. It is possible that micro-
g l i a la c t i v a t i o ni n i t i a l l yr e s u l t si na ne l e v a t i o no fS R
expression (via the AP-1 transcription factor, as
described [27]), a substantial fraction of which would
be active, noncovalent dimer. The subsequent oxida-
tive conditions may then crosslink these dimers via as
yet undefined reactions.
Conclusions
We have obtained data confirming that human serine
racemase is most active as a noncovalent dimer. The
optimal catalytic activity of the enzyme appears to con-
tain one or more free sulfhydryls; these may be located
in the active site or they may effect modulation allosteri-
cally. Likely owing to these sulfhydryls, reduction/oxida-
tion status during production and purification of SR can
dramatically impact specific activity. We also documen-
ted a surprising effect of buffer composition on activity,
providing cautionary information for interpretations of
SR activity. The structural characteristics of SR obtained
from live cells suggest that SR is sensitive to oxidation
in vivo, perhaps consistent with a scenario in which
such modification plays a role in feedback or other
forms of regulation.
Methods
Recombinant expression of human SR
Full-length SR cDNA was obtained by reverse transcrip-
tion-polymerase chain reaction (RT-PCR) from human
brain mRNA. Two oligonucleotides were used to
amplify the cDNA: forward primer, 5’-ATA GGA TCC
TGA GCT GAG AAC CAT GTG TG-3’ and reverse
primer, 5’-GGA AAT GGT GGG AAT TCA GTG GAT
CCT AT- 3’, where novel BamHI sites (underlined
sequences) were introduced before the initiation Met
residue and after the “stop” codon. The amplified frag-
ment of DNA (1085 bp) was digested with BamHI and
subcloned into pcDNA3.1 plasmid (Invitrogen). The
pcDNA3.1-SR plasmid was then digested with BamHI,
and the excised fragment of DNA was ligated into the
corresponding sites of the pTrcHisB expression vector
(Invitrogen). After DNA sequence verification,
pTrcHisB-SR vector was transformed into competent
BL21 (DE3) E. coli (Invitrogen). A 20-ml overnight cul-
ture was grown and used to inoculate 480 ml of fresh
Luria-Bertani (LB) medium containing 50 μg/ml carbe-
nicillin (Sigma). Typically, the cultures were grown at
37°C with shaking until they reached mid-log (OD600 =
0.6). Expression from the pTrcHisB-SR vector was then
induced by the addition of 0.75 mM isopropyl-1-thio-b-
D-galactopyranoside (IPTG, Fisher Scientific), and the
culture was incubated for an additional 3-4 h at 37°C.
The cells were collected by centrifugation at 3500 rpm
for 30 min and stored at -80°C.
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The frozen cell pellet was resuspended in native binding
buffer (50 mM phosphate buffer, pH 8.0, 52 mM NaCl)
with 1 mg/ml lysozyme on ice, and the cells were lysed
by sonication (six cycles of 30 s with a 30-s cooling per-
iod on ice between each cycle). The supernatant of the
lysate was obtained by centrifugation at 12,000 × g for
40 min. All the purification steps were performed at 0-
4°C. Because the pTrcHisB-SR vector has a hexahisti-
dine tag translated at the N-terminus of SR, purification
of the protein was initially performed by affinity chro-
matography. The cellular supernatant was loaded on to
a5 - m lP r o B o n d ™ nickel-chelating resin column (Invi-
trogen). The column was washed with 40 ml wash buf-
fer (50 mM phosphate buffer, pH 8.0, 52 mM NaCl, and
100 mM imidazole). Then the protein was eluted with
elution buffer (50 mM phosphate buffer, pH 8.0, 52 mM
NaCl, and 250 mM imidazole). The recombinant SR in
each fraction was detected by sodium dodecyl sulphate
polyacrylamide gel electrophoresis (SDS-PAGE). Frac-
tions with highest concentrations of SR were pooled
together and extensively dialyzed against the assay buf-
fer’s base [50 mM phosphate buffer, pH 8.0, 52 mM
NaCl, 0.2 mM DTT (Fisher Scientific)], first with
Tween-20 (0.1%) and then without. After dialysis, pro-
teins were kept at 4°C for structure and activity analysis.
Enzyme assay
The activity of SR was measured by the velocity of race-
mization reaction of L-serine to D-serine, the latter of
which was assayed by a chemiluminescence assay. The
procedure for enzyme reaction was modified and opti-
m i z e df r o mad e s c r i b e dp r o t o c o l[ 3 7 ] .T om i n i m i z et h e
level of the D-serine that contaminates virtually all com-
mercial L-serine reagents, L-serine (Sigma) was catabo-
lized with porcine kidney D-amino acid oxidase (DAO,
Calzyme Laboratories) as follows: up to 200 mM L-ser-
ine was combined with 1.5 U/ml porcine DAO, 3 U/μl
catalase (Sigma) and 84 μg/ml flavin adenine dinucleo-
tide (FAD, Calbiochem) in 0.15 M Tris-HCl, pH 8.3; the
mixture was incubated at 37°C overnight, then was
heated at 95°C for 10 min to inactivate the enzymes.
The supernatant was collected after centrifugation at
14,000 × g for 10 min. Removal of D-serine was con-
firmed by a D-serine chemiluminescence assay, which
indicated that DAO pretreatment reduced the levels of
contaminating D-serine by a factor of 20-fold.
SR activity assay was performed with 2.5 μg recombi-
nant enzyme in the presence of 50 mM phosphate buf-
fer, pH 8.0, 52 mM NaCl, 15 μM PLP, 1 mM ATP, 0.2
mM DTT, 1 mM MgCl2 and 10 mM pretreated L-serine
in a final reaction volume of 50 μl. After the mixture
was incubated at 37°C for 30 min, the reaction was ter-
minated by boiling for 5 min. Control incubations for
the subtraction of background started with enzyme pre-
parations that had been inactivated by boiling.
The D-serine produced during incubation was moni-
tored by a subsequent chemiluminescence assay. Cata-
bolism of D-serine by DAO generates an a-keto acid,
NH4
+, and hydrogen peroxide. The generation of hydro-
gen peroxide was quantified by the use of peroxidase
and luminol, which emits light. A 10-μl aliquot of sam-
ple or D-serine standard was added to 50 μl of buffer
containing 100 mM Tris-HCl, pH 8.8, 50 mM NaCl, 2
units/ml horseradish peroxidase (HRP, Sigma), 16 μM
luminol (Sigma), and 0.8 μg/ml FAD. After a 10- to 20-
minute delay, required to decrease a nonspecific luminol
luminescence, 60 μlo fR. gracilis DAO (0.033 U/ml,
recombinant; courtesy of L. Pollegioni, U. Insubria, Var-
ese, Italy) was added. A Veritas Microplate Lumin-
ometer (Turner Biosystems Inc.) was used to detect
luminescence before and after addition of DAO. The
value obtained immediately before DAO signal (i.e.,
after extinction of the nonspecific luminescence) was
subtracted from what obtained after DAO, and this
remainder was used to calibrate and calculate the D-ser-
ine content. KM and Vmax of SR reactions were calcu-
lated from nonlinear regressions using Graphpad Prism
software.
Gel-filtration analysis of recombinant SR
Aliquots of 50 μl of ~5 mg/ml of recombinant SR were
loaded onto a Superdex HR200 gel-filtration column
(GE) equilibrated with one of two buffers: 1) 50 mM
phosphate buffer, pH 8.0, 52 mM NaCl; or 2) 50 mM
Tris-HCl, pH 8.0, 150 mM NaCl. Protein was detected
by measuring absorption at 280 nm. The flow rate was
kept at 0.5 ml/min. The column void volume was deter-
mined with dextran blue. The column was calibrated
with proteins from a preparation of gel-filtration stan-
dards (Sigma), including cytochrome c (12.4 kDa), car-
bonic anhydrase (29 kDa), bovine serum albumin (66
kDa), alcohol dehydrogenase (150 kDa), and b-amylase
(200 kDa). The calibration curve was obtained by plot-
ting the Ve/Vo ratio against the log of the molecular
weight, where Ve is the elution volume of the protein
and Vo is the void volume of the column.
Protein cross-linking experiments
Recombinant SR (12.5 μM) was incubated with various
concentrations of protein cross-linker BS
3 (Pierce) in
cross-linking buffer [50 mM borate buffer, pH 8.0 with
0.5% Triton X-100 (Sigma), 2 mM EDTA, 150 mM
NaCl, and 0.2 mM phenylmethylsulfonyl fluoride
(PMSF)] on ice for 2 hours. The reactions were
quenched by adding 30 mM Tris-HCl, pH 7.5. The for-
mation of cross-linked SR protein was analyzed with
10% SDS-PAGE. The gels were stained with Coomassie
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cross-linked; lysates were extracted in cross-linking buf-
fer on ice and cleared by centrifugation at 14,000 g for
10 minutes at 4°C. Supernatants (0.5 μg/μl) were incu-
bated with various concentrations of protein cross-linker
BS
3 in cross-linking buffer on ice for 2 h. The reactions
were quenched by adding 30 mM Tris-HCl, pH 7.5. The
formation of cross-linked SR protein was analyzed by
western blot assay with anti-SR antibody (BD
Biosciences).
Cell culture
Primary mouse glial cultures were established from cere-
bral cortex of C57BL/6 mice essentially as described
[26]. When primary cultures reached confluency (1-2
weeks), flasks were shaken overnight at 200 rpm at 37°
C. The supernatant containing microglia was removed
and fresh medium was added to the flasks, which were
incubated for another 5-7 days. This procedure was
repeated three to four times after which cells were tryp-
sinized and resuspended in astrocyte medium compris-
ing minimal essential medium (MEM), 10% fetal bovine
serum (FBS), and 0.1 mM L-leucine methyl ester (L-
LME, Sigma-Aldrich) to eliminate any remaining micro-
glia. Astrocytes were treated with L-LME for two weeks
and were subcultured for experiments by trypsinization.
Western blot analysis of SR
Amounts of recombinant SR or cell extracts equilibrated
for protein content were resolved by 10% SDS-PAGE.
Protein was electrophoretically transferred at 100 V for
1.5 h onto nitrocellulose membranes, which were then
blocked for 1 h at room temperature with 0.2% I-Block
(Applied Biosystems). A monoclonal antibody generated
against mouse SR (BD Biosciences) was diluted 1:500 in
I-Block and applied overnight at 4°C. The blots were
then developed with one of the following two methods:
1) for chemiluminescence detection, the membranes
were incubated with alkaline phosphatase-conjugated
goat anti-mouse antibody (1:2000) and then developed
with the Western-Light detection system (Applied Bio-
systems); 2) for colorimetric detection, the membranes
were incubated with alkaline phosphatase-conjugated
rabbit anti-mouse antibody at 1:400, and then developed
with BCIP/NBT kit (Vector Laboratories).
Statistical analysis
Data are expressed as mean ± standard deviation. Data
were analyzed using one-way ANOVA followed by post
hoc comparisons. A p-value ≤ 0.05 was considered sta-
tistically significant.
Acknowledgements and funding
This work was supported by the National Institute on Aging (USA)
[P01AG012411].
Author details
1Department of Geriatrics, University of Arkansas for Medical Sciences, Little
Rock AR 72205, USA.
2Department of Neurobiology & Developmental
Sciences, University of Arkansas for Medical Sciences, Little Rock AR 72205,
USA.
3Geriatric Research Education and Clinical Center, Central Arkansas
Veterans Healthcare System, Little Rock AR 72205, USA.
Authors’ contributions
WW carried out all the technical aspects of this study, including cloning of
human SR, construction of the expression vector, purification, and assay of
SR activity. She also drafted the manuscript. SWB initiated the study,
participated in its design and coordination, and completed the final
revisions of the manuscript. All authors read and approved the final
manuscript.
Authors’ information
WW performed these studies in partial satisfaction of her dissertation
requirements for a Ph.D. in the Dept. Neurobiol. & Dev. Sci. at Univ. Arkansas
Med. Sci.; she is currently a postdoctoral scholar in the Dept. of Geriatrics.
She previously obtained a B.S. in biochemistry and an M.S. in molecular
immunology from Lanzhou Univ. in Gansu, P.R. China, where she received
three academic scholarships. SWB obtained a Ph.D. in cell biology from
Vanderbilt Univ. and completed postdoctoral training at the Sanders-Brown
Center on Aging at Univ. Kentucky. He is currently a Professor in the Dept.
of Geriatrics and in the Dept. of Neurobiol. & Dev. Sci. at Univ. Arkansas
Med. Sci.; he is also a Research Health Scientist in the Geriatric Research
Education and Clinical Center at the Central Arkansas Veterans Healthcare
System. He has served as president of the Arkansas Chapter of the Society
for Neuroscience and as a member of the Society for Neuroscience’s
Committee for Animals in Research; he is currently a member of Council for
the American Society for Neurochemistry. He has served on five NIH study
sections and special emphasis panels and currently sits on the editorial
boards for Current Alzheimer Research, Journal of Neurochemistry, Journal of
Neuroinflammation, Journal of Neuroscience Research, Neurobiology of Aging.
Received: 15 July 2011 Accepted: 8 December 2011
Published: 8 December 2011
References
1. Hashimoto A, Nishikawa T, Hayashi T, Fujii N, Harada K, Oka T, Takahashi K:
The presence of free D-serine in rat brain. FEBS Lett 1992, 296:33-36.
2. Wolosker H, Sheth KN, Takahashi M, Mothet JP, Brady RO Jr, Ferris CD,
Snyder SH: Purification of serine racemase: biosynthesis of the
neuromodulator D-serine. Proc Natl Acad Sci USA 1999, 96:721-725.
3. Schell MJ, Brady RO Jr, Molliver ME, Snyder SH: D-serine as a
neuromodulator: regional and developmental localizations in rat brain
glia resemble NMDA receptors. J Neurosci 1997, 17:1604-1615.
4. Schell MJ, Molliver ME, Snyder SH: D-serine, an endogenous synaptic
modulator: localization to astrocytes and glutamate-stimulated release.
Proc Natl Acad Sci USA 1995, 92:3948-3952.
5. Mothet JP, Parent AT, Wolosker H, Brady RO Jr, Linden DJ, Ferris CD,
Rogawski MA, Snyder SH: D-serine is an endogenous ligand for the
glycine site of the N-methyl-D- aspartate receptor. Proc Natl Acad Sci USA
2000, 97:4926-4931.
6. Stevens ER, Esguerra M, Kim PM, Newman EA, Snyder SH, Zahs KR, Miller RF:
D-serine and serine racemase are present in the vertebrate retina and
contribute to the physiological activation of NMDA receptors. Proc Natl
Acad Sci USA 2003, 100:6789-6794.
7. Labrie V, Fukumura R, Rastogi A, Fick LJ, Wang W, Boutros PC, Kennedy JL,
Semeralul MO, Lee FH, Baker GB, et al: Serine racemase is associated with
schizophrenia susceptibility in humans and in a mouse model. Hum Mol
Genet 2009, 18:3227-3243.
8. Inoue R, Hashimoto K, Harai T, Mori H: NMDA- and beta-amyloid1-42-
induced neurotoxicity is attenuated in serine racemase knock-out mice.
J Neurosci 2008, 28:14486-14491.
Wang and Barger BMC Biochemistry 2011, 12:63
http://www.biomedcentral.com/1471-2091/12/63
Page 10 of 119. Gaspar PA, Bustamante ML, Silva H, Aboitiz F: Molecular mechanisms
underlying glutamatergic dysfunction in schizophrenia: therapeutic
implications. J Neurochem 2009, 111:891-900.
10. Labrie V, Roder JC: The involvement of the NMDA receptor D-serine/
glycine site in the pathophysiology and treatment of schizophrenia.
Neurosci Biobehav Rev 2010, 34:351-372.
11. Turpin FR, Potier B, Dulong JR, Sinet PM, Alliot J, Oliet SH, Dutar P,
Epelbaum J, Mothet JP, Billard JM: Reduced serine racemase expression
contributes to age-related deficits in hippocampal cognitive function.
Neurobiol Aging 2009, 32:1495-1504.
12. Sasabe J, Chiba T, Yamada M, Okamoto K, Nishimoto I, Matsuoka M, Aiso S:
D-serine is a key determinant of glutamate toxicity in amyotrophic
lateral sclerosis. Embo J 2007, 26:4149-4159.
13. Neidle A, Dunlop DS: Allosteric regulation of mouse brain serine
racemase. Neurochem Res 2002, 27:1719-1724.
14. De Miranda J, Santoro A, Engelender S, Wolosker H: Human serine
racemase: molecular cloning, genomic organization and functional
analysis. Gene 2000, 256:183-188.
15. Cook SP, Galve-Roperh I, Martinez Del Pozo A, Rodriguez-Crespo I: Direct
calcium binding results in activation of brain Serine Racemase. J Biol
Chem 2002, 20:27782-27792.
16. Shoji K, Mariotto S, Ciampa AR, Suzuki H: Regulation of serine racemase
activity by D-serine and nitric oxide in human glioblastoma cells.
Neurosci Lett 2006, 392:75-78.
17. Shoji K, Mariotto S, Ciampa AR, Suzuki H: Mutual regulation between
serine and nitric oxide metabolism in human glioblastoma cells. Neurosci
Lett 2006, 394:163-167.
18. Mustafa AK, Kumar M, Selvakumar B, Ho GP, Ehmsen JT, Barrow RK,
Amzel LM, Snyder SH: Nitric oxide S-nitrosylates serine racemase,
mediating feedback inhibition of D-serine formation. Proc Natl Acad Sci
USA 2007, 104:2950-2955.
19. Dunlop DS, Neidle A: Regulation of serine racemase activity by amino
acids. Brain Res Mol Brain Res 2005, 133:208-214.
20. Strisovsky K, Jiraskova J, Mikulova A, Rulisek L, Konvalinka J: Dual substrate
and reaction specificity in mouse serine racemase: identification of high-
affinity dicarboxylate substrate and inhibitors and analysis of the beta-
eliminase activity. Biochemistry 2005, 44:13091-13100.
21. Mustafa AK, van Rossum DB, Patterson RL, Maag D, Ehmsen JT, Gazi SK,
Chakraborty A, Barrow RK, Amzel LM, Snyder SH: Glutamatergic regulation
of serine racemase via reversal of PIP2 inhibition. Proc Natl Acad Sci USA
2009, 106:2921-2926.
22. Kim PM, Aizawa H, Kim PS, Huang AS, Wickramasinghe SR, Kashani AH,
Barrow RK, Huganir RL, Ghosh A, Snyder SH: Serine racemase: activation
by glutamate neurotransmission via glutamate receptor interacting
protein and mediation of neuronal migration. Proc Natl Acad Sci USA
2005, 102:2105-2110.
23. Baumgart F, Mancheno JM, Rodriguez-Crespo I: Insights into the activation
of brain serine racemase by the multi-PDZ domain glutamate receptor
interacting protein, divalent cations and ATP. Febs J 2007, 274:4561-4571.
24. Fujii K, Maeda K, Hikida T, Mustafa AK, Balkissoon R, Xia J, Yamada T,
Ozeki Y, Kawahara R, Okawa M, et al: Serine racemase binds to PICK1:
potential relevance to schizophrenia. Mol Psychiatry 2006, 11:150-157.
25. Hikida T, Mustafa AK, Maeda K, Fujii K, Barrow RK, Saleh M, Huganir RL,
Snyder SH, Hashimoto K, Sawa A: Modulation of D-serine levels in brains
of mice lacking PICK1. Biol Psychiatry 2008, 63:997-1000.
26. Wu S-Z, Bodles AM, Porter MM, Griffin WST, Basile AS, Barger SW: Induction
of serine racemase expression and D-serine release from microglia by
amyloid b-peptide. J Neuroinflammation 2004, 1:2-12.
27. Wu S-Z, Barger SW: Serine racemase induction by inflammatory stimuli is
dependent on AP-1. Ann N Y Acad Sci 2004, 1035:133-146.
28. Smith MA, Mack V, Ebneth A, Moraes I, Felicetti B, Wood M, Schonfeld D,
Mather O, Cesura A, Barker J: The structure of mammalian serine
racemase: evidence for conformational changes upon inhibitor binding.
J Biol Chem 2010, 285:12873-12881.
29. D’Autreaux B, Toledano MB: ROS as signalling molecules: mechanisms
that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol 2007,
8:813-824.
30. Denu JM, Tanner KG: Specific and reversible inactivation of protein
tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic
acid intermediate and implications for redox regulation. Biochemistry
1998, 37:5633-5642.
31. Kettenhofen NJ, Wood MJ: Formation, reactivity, and detection of protein
sulfenic acids. Chem Res Toxicol 2010, 23:1633-1646.
32. Spadaro D, Yun BW, Spoel SH, Chu C, Wang YQ, Loake GJ: The redox
switch: dynamic regulation of protein function by cysteine
modifications. Physiol Plant 2010, 138:360-371.
33. Mieyal JJ, Gallogly MM, Qanungo S, Sabens EA, Shelton MD: Molecular
mechanisms and clinical implications of reversible protein S-
glutathionylation. Antioxid Redox Signal 2008, 10:1941-1988.
34. Lindahl M, Mata-Cabana A, Kieselbach T: The disulfide proteome and
other reactive cysteine proteomes: analysis and functional significance.
Antioxid Redox Signal 2011, 14:2581-2642.
35. Wu S, Basile AS, Barger SW: Induction of serine racemase expression and
D-serine release from microglia by secreted amyloid precursor protein
(sAPP). Curr Alzheimer Res 2007, 4:243-251.
36. Zhang H, Andrekopoulos C, Joseph J, Chandran K, Karoui H, Crow JP,
Kalyanaraman B: Bicarbonate-dependent peroxidase activity of human
Cu, Zn-superoxide dismutase induces covalent aggregation of protein:
intermediacy of tryptophan-derived oxidation products. J Biol Chem
2003, 278:24078-24089.
37. Wolosker H, Blackshaw S, Snyder SH: Serine racemase: a glial enzyme
synthesizing D-serine to regulate glutamate-N-methyl-D-aspartate
neurotransmission. Proc Natl Acad Sci USA 1999, 96:13409-13414.
doi:10.1186/1471-2091-12-63
Cite this article as: Wang and Barger: Roles of quaternary structure and
cysteine residues in the activity of human serine racemase. BMC
Biochemistry 2011 12:63.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Wang and Barger BMC Biochemistry 2011, 12:63
http://www.biomedcentral.com/1471-2091/12/63
Page 11 of 11